País: Suecia
Idioma: sueco
Fuente: Läkemedelsverket (Medical Products Agency)
acetylsalicylsyra
Krka d.d., Novo mesto
B01AC06
acetylsalicylic acid
160 mg
Enterotablett
acetylsalicylsyra 160 mg Aktiv substans; laktosmonohydrat Hjälpämne; natriumlaurilsulfat Hjälpämne
Receptbelagt
Förpacknings: Blister, 28 tabletter; Blister, 30 tabletter; Blister, 50 tabletter; Blister, 56 tabletter; Blister, 60 tabletter; Blister, 84 tabletter; Blister, 90 tabletter; Blister, 100 tabletter
Godkänd
2017-02-10
PACKAGE LEAFLET: INFORMATION FOR THE USER ACETYLSALICYLIC ACID KRKA 75 MG GASTRO-RESISTANT TABLETS ACETYLSALICYLIC ACID KRKA 100 MG GASTRO-RESISTANT TABLETS ACETYLSALICYLIC ACID KRKA 160 MG GASTRO-RESISTANT TABLETS acetylsalicylic acid _[For medicines available only on prescription:]_ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. _[For medicines available without a prescription:]_ READ ALL OF THIS LEAFLET CAREFULLY BEFORE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist or nurse has have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET 1. What Leer el documento completois and what it is used for 2. What you need to know before you take 3. How to take 4. Possible side effects 5. How to store 6. Contents of the pack and other information 1. WHAT IS AND WHAT IT IS USED FOR contains acetylsalicylic acid, which in low doses belong to a group of medicines called anti-platelet agents. Platelets are tiny cells in the blood that cause the blood to clot and are involved in thrombosis. When a blood clot occurs in an
PRODUKTRESUMÉ 1. LÄKEMEDLETS NAMN Acetylsalicylic acid Krka 75 mg enterotabletter Acetylsalicylic acid Krka 100 mg enterotabletter Acetylsalicylic acid Krka 160 mg enterotabletter 2. KVALITATIV OCH KVANTITATIV SAMMANSÄTTNING Varje enterotablett innehåller 75 mg, 100 mg eller 160 mg acetylsalicylsyra. Hjälpämnen med känd effekt: 75 mg: Laktosmonohydrat...........................................................................................45 mg per tablett. Para-orange (E110) ..................................................................................0,0006 mg per tablett. 100 mg: Laktosmonohydrat …………………………………………………………60 mg per tablett. 160 mg: Laktosmonohydrat...........................................................................................96 mg per tablett. Sojalecitin (E322).........................................................................................0,42 mg per tablett. För fullständig förteckning över hjälpämnen, se avsnitt 6.1. 3. LÄKEMEDELSFORM Enterotablett 75 mg: rosa, runda, bikonvexa enterotabletter med en diameter på ungefär 7,2 mm. 100 mg: Vita, runda, bikonvexa enterotabletter med en diameter på ungefär 8,1 mm. 160 mg: gula, runda, bikonvexa enterotabletter med en diameter på ungefär 9,2 mm. 4. KLINISKA UPPGIFTER 4.1 TERAPEUTISKA INDIKATIONER - Sekundärprofylax efter hjärtinfarkt. - Profylax mot kardiovaskulär dödlighet hos patienter med stabil angina pectoris. - Anamnes på instabil angina pectoris, förutom under den akuta fasen. - Profylax mot graftocklusion efter CABG (Coronary Artery Bypass Grafting). - Vidkoronarangioplastik, förutom under den akuta fasen. - Sekundärprofylax efter TIA (transitoriska ischemiska attacker) och ischemiska cerebrovaskulära händelser, givet att intracerebral blödning har uteslutits. Acetylsalicylic acid Krka rekommenderas ej vid akuta situationer. Användningen är begränsad till sekundärprofylax vid kronisk behandling. 4.2 DOSERING OCH ADMINISTRERINGSSÄTT Doserin Leer el documento completo